DEC-2014 : Grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials
MWV’s MEMS® System chosen for trials of HIV-prevention medication in Africa and India.
Global packaging company has received a grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials
Liège, Belgium and Manchester, UK; August 2025: AARDEX Group, a global leader in digital medication adherence solutions, and Pill Connect, a pioneer in connected dispensing technology, have announced a strategic partnership to support a multi-cohort Phase 2A dose selection trial.
Medication adherence is an element of successful clinical research. It refers to the degree to which a patient follows a prescribed medication regimen including when and how often the medication is taken, and whether it is discontinued prematurely. In clinical